HealthEquity (NASDAQ:HQY) Given Outperform Rating at Barrington Research

HealthEquity (NASDAQ:HQY)‘s stock had its “outperform” rating reissued by research analysts at Barrington Research in a report released on Friday,Benzinga reports. They presently have a $112.00 price target on the stock. Barrington Research’s price objective indicates a potential upside of 19.19% from the company’s current price.

HQY has been the topic of a number of other research reports. Mizuho assumed coverage on HealthEquity in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price on the stock. The Goldman Sachs Group started coverage on shares of HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 price target for the company. Wells Fargo & Company boosted their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. Raymond James raised their target price on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Tuesday, February 25th. Finally, Royal Bank of Canada lifted their price target on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $112.92.

HealthEquity Trading Down 1.9 %

Shares of NASDAQ:HQY opened at $93.97 on Friday. The firm has a market cap of $8.14 billion, a price-to-earnings ratio of 86.21, a PEG ratio of 1.60 and a beta of 0.62. HealthEquity has a 12 month low of $65.01 and a 12 month high of $115.59. The company’s fifty day simple moving average is $105.68 and its 200 day simple moving average is $94.93. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the company posted $0.40 earnings per share. As a group, research analysts forecast that HealthEquity will post 2.32 EPS for the current fiscal year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 2.20% of the company’s stock.

Institutional Trading of HealthEquity

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Arcadia Investment Management Corp MI bought a new stake in shares of HealthEquity during the fourth quarter worth approximately $26,000. Transce3nd LLC acquired a new stake in HealthEquity during the 4th quarter worth approximately $29,000. Smartleaf Asset Management LLC boosted its stake in HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after purchasing an additional 98 shares during the period. Proficio Capital Partners LLC acquired a new position in HealthEquity in the 4th quarter valued at $39,000. Finally, UMB Bank n.a. increased its position in HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after buying an additional 164 shares during the period. Institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.